SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-011469
Filing Date
2018-08-20
Accepted
2018-08-20 17:28:02
Documents
55
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0618_americanbrivision.htm 10-Q 402129
2 CERTIFICATION f10q0618ex31-1_american.htm EX-31.1 9450
3 CERTIFICATION f10q0618ex31-2_american.htm EX-31.2 9605
4 CERTIFICATION f10q0618ex32-1_american.htm EX-32.1 3619
5 CERTIFICATION f10q0618ex32-2_american.htm EX-32.2 3690
  Complete submission text file 0001213900-18-011469.txt   2678833

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE abvc-20180630.xml EX-101.INS 423791
7 XBRL SCHEMA FILE abvc-20180630.xsd EX-101.SCH 34589
8 XBRL CALCULATION FILE abvc-20180630_cal.xml EX-101.CAL 38653
9 XBRL DEFINITION FILE abvc-20180630_def.xml EX-101.DEF 92846
10 XBRL LABEL FILE abvc-20180630_lab.xml EX-101.LAB 207867
11 XBRL PRESENTATION FILE abvc-20180630_pre.xml EX-101.PRE 174361
Mailing Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924
Business Address 11 SAWYERS PEAK DRIVE GOSHEN NY 10924 845-551-8728
American BriVision (Holding) Corp (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-91436 | Film No.: 181028994
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1